# Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

> **NCT01968187** · PHASE2 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 38 (actual)

## Conditions studied

- Hyperphagia in Prader-Willi Syndrome

## Interventions

- **DRUG:** FE 992097
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01968187
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-20
- **Primary completion:** 2014-07-16
- **Final completion:** 2014-07-16
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2025-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01968187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01968187, "Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01968187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*